Guidance

Diabetic eye screening: optical coherence tomography in surveillance

Guidance for diabetic eye screening providers on use of optical coherence tomography (OCT) in surveillance clinics.

• From: NHS England
• Published: 8 July 2020
• Last updated: 16 April 2025
  Show all updates

  1. 16 April 2025

     Removed withdrawn optical coherence tomography (OCT) in diabetic eye screening (DES) surveillance clinics guidance. Removed PHE gateway reference numbers.

  2. 27 September 2024

     Added clarification that publication was previously published by Public Health England.

  3. 10 July 2024

     Removed PHE

  4. 10 July 2024

     Updated guidance

  5. 8 July 2020

     First published.

Applies to England

Documents

Optical coherence tomography (OCT) in diabetic eye screening (DES) surveillance clinics

HTML

OCT examples

HTML

Diabetic eye screening: OCT in surveillance pathway

HTML

Details

This document provides consistent best practice guidance for diabetic eye screening (DES) services on the management of diabetic maculopathy in digital surveillance (DS) clinics using optical coherence tomography (OCT).